The Russian Pharmaceutical Market: Lessons Learned
We are in the early days of a short, but intense consulting project involving the Russian pharmaceutical market. It's a very interesting market, with some notable differences when compared…
We are in the early days of a short, but intense consulting project involving the Russian pharmaceutical market. It's a very interesting market, with some notable differences when compared…
The coverage of the announced negotiation by Sanofi to divest its European generics business triggered this cranky post. I don’t quite understand why so many journalists/analysts negatively criticize management when…